Improving treatment responses for pancreatic cancer
Pancreatic Cancer ARTNet Center
This study is looking into why pancreatic cancer patients sometimes don’t respond well to regular chemotherapy and aims to find new treatment options that could work better for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-10926921 on NIH RePORTER |
What this research studies
This research focuses on understanding why pancreatic cancer patients often do not respond well to standard chemotherapy and how they develop resistance to these treatments. By investigating the signaling and metabolic changes in tumor cells and their surrounding environment, the research aims to identify new therapeutic combinations that can enhance treatment effectiveness. The project will also coordinate efforts with various cancer research networks to ensure comprehensive progress in tackling this challenging disease. Patients may benefit from novel therapies developed through this research that target the mechanisms of resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer who are undergoing or have undergone chemotherapy.
Not a fit: Patients with pancreatic cancer who are not receiving chemotherapy or those with advanced disease not amenable to treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, improving patient outcomes and survival rates.
How similar studies have performed: Previous research has shown promise in targeting cancer resistance mechanisms, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Singh, Pankaj Kumar — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Singh, Pankaj Kumar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.